International Journal of Oncology Research is an open access, peer reviewed, multidisciplinary journal focused to publish articles on developments of all types of malignancies including pathology, diagnosis and therapy, including radiotherapy, and systemic treatment. Articles submitted to the journal will be subjected to standard peer review process to ensure the quality of submitted content.
The journal invites significant and up-to-date articles within the fields of experimental and clinical oncology. The articles on aspects covering apoptosis, biotherapeutics, bone marrow transplantation, cancer biology, cancer epidemiology, cancer etiology, cancer prevention, cancer rehabiliation medicine, cancer screening and diagnosis, cell differentiation & proliferation, chemotherapeutic agents, clinical imaging, cytogenetics, emerging therapeutics, flow cytometry, general hematology and oncology, medical oncology, molecular biology module, neoplasms, oncologic emergencies, oncology nursing, principals of endocrine therapy, principles of cancer pathology, psyco oncology, radiation oncology, societal oncology, surgical oncology, transfusion medicine, tumor immunology, etc.
Journal Information
Title: International Journal of Oncology Research
ISSN: 2643-4563
Editor-in-chief: Osamu Tanaka
NLM title abbreviation: Int J Oncol Res
ISO abbreviation: Int J Oncol Res
Other titles: IJOR
Category: Oncology/Cancer
DOI: 10.23937/2643-4563
Peer review: Double blind
Review speed: 3 weeks
Fast-track review: 10 days
Publication format (s): Electronic and print
Publication policy: Open Access; COPE guide
Publication type(s): Periodicals
Publisher: ClinMed International Library
Country of publication: USA
Language: English
Contact email: contact@clinmedjournals.org
Articles Search by Keyword | Journal title | Author name | DOI
Open Access DOI:10.23937/2643-4563/1710046 Nidhal Belloumi, Chaima Habouria, Hana Mrassi, Malak Maamar, Imen Bachouch, Fatma Chermiti and Soraya Fenniche Article Type: Original Article | First Published: October 05, 2022 Interactions between cancer genesis, sleep quality and patient’s humor engage complex pathophysiological pathways. However, the outcome of various indicators of quality of life (Qol) after chemotherapy in non small cells lung cancer (NSCLC) and also their prognostic impact remain understudied. The objective of this study was to analyze the Qol, sleep quality and anxio-depressive disorder in advanced NSCLC patients put on chemotherapy....
| |
Open Access DOI:10.23937/2643-4563/1710045 Leiomyosarcoma of the Inferior Vena Cava Presenting as a Renal Mass: A Case Report Hind Saad Al-Otaibi, Mohammed Hassan Ahmed, Ghaidaa Naser AbdulRazak, David Bakiratharajan, Talal Abdulla Alanzi and Tarek Essam Eldin Ahmed Article Type: Case Report | First Published: August 29, 2022 Leiomyosarcomas (LMS) are rare tumors associated with poor outcomes. Treatment of the condition is challenging due to limited cases in the literature. Here, we present a case of a 46-year-old male who presented with left lower limb deep vein thrombosis, with an ultrasound scan revealing a right renal mass. MRI demonstrated a large, well-circumscribed lesion engulfing the middle and lower right renal poles associated with an invasion of the related part of the inferior vena cava (IVC), right rena...
| |
Open Access DOI:10.23937/2643-4563/1710044 Ritu Mehta and Rashmi Yadav Article Type: Original Article | First Published: August 29, 2022 To study the prevalence of Cyclin D1 expression and its correlation with other clinicopathological parameters like age, tumor size, lymph node status, MBR grade, and expression of other immunohistochemical markers like ER, PR, Her 2 - neu, and Ki67. Thirty cases diagnosed were included in the study. All the cases were subjected to routine histopathology along with IHC for ER PR, Her2-neu, Ki67, and Cyclin D1....
| |
Open Access DOI:10.23937/2643-4563/1710043 Karishma Chhabria, MPH, PhD, Mark Bonnen, MD, Joshua Asper, PA-C, Giselle D Carnaby, MPH, PhD Article Type: Systematic Review | First Published: September 12, 2022 Head and neck cancer (HNC) patients undergoing chemo/radiation commonly experience severe and persistent distress associated with treatment related fear and physical side effects such as xerostomia, dysphagia, and dryness of mouth. Cortisol, a stress sensitive hormone, can be easily measured in saliva to reflect biobehavioral responses to such stressors. Unfortunately, it has not been used in this population due to concerns associated with chemoradiation (C/RT) related xerostomia....
| |
Open Access DOI:10.23937/2643-4563/1710042 Breast Cancer in Men: A Systematic Review of the Literature from the Arab World Pierre El Sett, Georges Jammal, Antoine El Sett, Ronaldo Elkaddoum, Hampig Raphael Kourie Article Type: Systematic Review | First Published: July 29, 2022 Breast Cancer (BC) is the most frequent cancer worldwide accounting for 11.7% of all cancers but only for 1% of men’s cancers; therefore, men’s breast cancer is rarely discussed, especially in the Arab World. This review, the first of its kind in the region, aims at reporting current trends in the epidemiology of BC in men, based on studies from the Arab region....
| |
Open Access DOI:10.23937/2643-4563/1710041 Sandra M Buitrago, Carolina Morante C, Laura Hernandez, Martha C Mendez Article Type: Clinical Case | First Published: June 30, 2022 Langerhans cell histiocytosis is a rare disease and due to its heterogeneous presentation represents a diagnostic and therapeutic challenge. We present the case of a patient with diabetes insipid us and panhypopituitarism, with the appearance of painful vulvar ulcers. The vulvar biopsy confirmed Langerhans cell histiocytosis with spreading to multiple organs, so it was decided to start chemotherapy, achieving the complete elimination of all lesions....
| |
Open Access DOI:10.23937/2643-4563/1710040 M Zaouit, N Benchakroun, Z Bouchbika, H Jouhadi, N Tawfiq, S Sahraoui, and A Benider Article Type: Abstract | First Published: June 30, 2022 Brain metastases are considered to be the most common malignant brain tumors in adults, and constitute a major challenge in oncology. The objective of our study is to analyze the epidemiological, clinical and paraclinical parameters of patients with brain metastases and treated by encephalic radiotherapy during the year 2020 at the Mohamed VI center of the Ibn Rochd CHU....
| |
Open Access DOI:10.23937/2643-4563/1710039 María Mercedes de la Torre-Bustamante, Juan Felipe Casabon-Pastrana, Diego Alejandro Largo- Cordoba, Diego Armando Gomajoa-Guerrero and Michael Gregorio Ortega-Sierra Article Type: Editorial | First Published: March 24, 2022 The COVID-19 pandemic has been one of the worst global public health crises of the 21st century. Global health was strongly affected by the dynamics of nations in the face of measures to contain the SARS-Cov-2 infection, such as confinement and redistribution of resources, which delayed the diagnosis and treatment of a large number of diseases, negatively modifying the prognosis and quality of life of these patients. The burden of surgical and oncological diseases is currently very high, and its...
| |
Open Access DOI:10.23937/2643-4563/1710038 Prognostic Value of the Ki67 Proliferation Index, CD10 and MUM1 in Follicular Lymphoma Minh Phuong Vu, Thanh Vui Le and Van Oanh Kieu Article Type: Original Article | First Published: March 24, 2022 Follicular lymphoma (FL) is an indolent lymphoma and is associated with a long survival time. However, there are patients who had an early progression after standard therapy. Our aim was to analyze the prognostic value of Ki67, CD10 and MUM1 expression in FL. Immunohistochemical staining for Ki67, CD10 and MUM1 was performed on formalin-fixed paraffinembedded biopsy tissues from 27 patients with FL. Patients were grouped according to the levels of the Ki67 proliferation index (PI). Survival time...
| |
Open Access DOI:10.23937/2643-4563/1710037 Impacts of Genetic Polymorphisms on Breast Cancer Hafez Ahmed and Mohamed Hussein Article Type: Review Article | First Published: March 16, 2022 Breast cancer (BC), a malignant proliferation of the epithelial cells that line the ducts or lobules of the breast, is the most common malignancy in women, accounting for approximately one-third of all cancers in women worldwide. According to its death rate, it is the second most frequent cancer causing mortality for women worldwide. Polymorphism involves one of two or more variants of a particular DNA sequence. The most common type of polymorphism involves variation at a single base pair. In re...
| |
Open Access DOI:10.23937/2643-4563/1710034 Olakayode V Ekundina, Chiamaka C Ejelue, Ondokeyi P Apulu and Ore-oluwa O Ayodele Article Type: Original Article | First Published: January 29, 2022 Monitoring and diagnosis of benign or premalignant breast lesions as it progresses to a malignant condition is very necessary for its ability to predict or curb the progression of a breast lesion to the malignant condition and Immunohistochemistry has been proven to be a useful tool in achieving this as immunohistochemical markers are corresponding and specific in nature. The primary objective of this case-control study is to study the expression of KI67, E-cadherin, and P53 in normal breast tis...
| |
Open Access DOI:10.23937/2643-4563/1710036 Bladder Neuroendocrine Carcinoma: About Five Cases and Review of the Literature Maryam Zaouit, Farida Marnissi, Hassan Jouhadi, Nadia Benchekroun, Asma Elkbir, Souha Sahraoui and Abdellatif Benider Article Type: Case series | First Published: February 07, 2022 This is a retrospective descriptive study of five cases of neuroendocrine carcinoma of the bladder collected at the Mohammed VI Center, between January 2017 and December 2020. The diagnosis was confirmed by immunohistochemical study. The median age is 61 years (extremes: 36-73 years), all patients are male. The average delay of consultation is 7 months (extremes: 2-12 months). Chronic smoking was found in three patients. Hematuria was the cardinal sign in 4 cases. Irritative urinary disorders su...
| |
Open Access DOI:10.23937/2643-4563/1710035 Yeliz VARIŞOĞLU, PhD and Pınar IRMAK VURAL, PhD Article Type: Original Article | First Published: January 31, 2022 The aim of this study was to determine the relationship between awareness of healthy lifestyle and breast cancer perception among women of reproductive age. This descriptive co relational study was conducted on 642 women. Data were collected using the sociodemographic data form, the Healthy Lifestyle Awareness Scale (HLAS), and the Breast Cancer Perception Scale (BCPS). A moderate, significant, and positive correlation was found between the HLAS total score and the scores obtained from the BCPS ...
| |
Open Access DOI:10.23937/2643-4563/1710033 Madli Tamm, Mart Kals, Tarmo Annilo, Kersti Oselin, Katrin Keerma, Paula Ann Kivistik, Miriam Nurm, Margot Saare, Jana Jaal and Neeme Tõnisson Article Type: Original Article | First Published: January 23, 2022 Cancer burden is a globally growing problem. Early diagnosis and targeted treatment decrease patients’ death rate, pain, and treatment expenses. Liquid biopsy can be used for early cancer detection, treatment selection, and progression and treatment response monitoring. We evaluated the performance of circulating cell-free DNA (cfDNA) and formalin-fixed paraffin-embedded (FFPE) tissue DNA analyses using a commonly employed targeted therapeutic pathway in predicting the outcomes of patients wit...
| |
Open Access DOI:10.23937/2643-4563/1710032 Nivolumab Induced Acute Pancreatitis and Hyperbilirubinemia Unnati Bhatia, MD, Suryansh Bajaj, MD, Darshan Gandhi, MD, Divyansh Bajaj, MD Article Type: Case Report | First Published: December 05, 2021 Immune checkpoint inhibitors (ICIs) are a novel treatment modality that is quickly becoming the standard of care for the management of a multitude of neoplasms. While immunomodulation is a promising approach, it also carries a risk of immune-related adverse effects (irAEs). Nivolumab is an FDA-approved anti-programmed death-1 (anti-PD-1) checkpoint inhibitor. Nivolumab-induced, immune-related pancreatitis, and hyperbilirubinemia are rare but clinically significant examples of irAEs. Early recogn...
| |
Open Access DOI:10.23937/2643-4563/1710031 Incidentally Found Thyroid Metastases in Head and Neck Squamous Cell Carcinoma - How to Manage It? Gama R, Oliveira P, Teixeira M, Castro F and Condé A Article Type: Original Article | First Published: September 10, 2021 The authors aim to review the available literature regarding incidentally found thyroid carcinoma during lymph node dissection for primary head and neck squamous cell carcinoma (SCC), in order to potentially support clinical decision about management of this unexpected entity. 2 clinical cases are described and a systematic review of the relevant literature on the subject is performed based on Pubmed® database. We reviewed a total of 102 cases. The primary SCCs sites were larynx, oral cavity, a...
| |
Open Access DOI:10.23937/2643-4563/1710030 Breast Metastases from Ovarian Primary: A Rare Entity and Review of Literature Suresh Singh, Bhalgat Bhushan Sanjay, Pravin Kumar, Kamal Kishore Lakhera, Phanindra Kumar Swain and Raj Govind Sharma Article Type: Case Report | First Published: July 24, 2021 Ovarian cancer is the fifth most frequent diagnosis of female malignancy and the second most common female gynecologic malignancy after breast cancer. The 5-year prevalence is 213 cases per million with 2.1 percent deaths as per GLOBOCON 2020 data. Clinical manifestations commonly include abdominal and pelvic pain with bloating, distention, urinary urgency and frequency, and unintended weight loss in the presence of tenderness to palpation and an adnexal mass on bimanual examination. Risk factor...
| |
Open Access DOI:10.23937/2643-4563/1710029 Epitope Spreading and the Efficacy of Immune Checkpoint Inhibition in Cancer W. Robert Liu, PhD and David E. Fisher, MD, PhD Article Type: Commentary | First Published: May 28, 2021 Therapeutic antibodies that target immune checkpoints have revolutionized cancer therapy. While these checkpoints restrain T cell activation in response to antigen engagement, checkpoint inhibitors de-repress such tumor-associated T cells, and have generated major clinical responses in multiple tumor types. Nonetheless, the vast majority of cancers remain resistant to this therapeutic approach as currently deployed, either through intrinsic or acquired resistance mechanisms. One key question inv...
| |
Open Access DOI:10.23937/2643-4563/1710028 On the Impact of Premature Termination of Chemotherapy on Relapse of Breast Cancer Heidrun Männle, Karsten Münstedt, Felix Momm and Jan Willem Siebers Article Type: Original Article | First Published: March 15, 2021 Some breast cancer patients receive a recommendation for adjuvant chemotherapy if necessary. In some cases, patients refuse this recommendation. In other cases, they start with chemotherapy, but then discontinue it. The question raised here are the effects of patients’ rejection or premature termination of recommended chemotherapies. 1916 patients, who received a recommendation for chemotherapy, were analyzed between 1997 and 2017. The analyses included descriptive analyses and Kaplan- Meier s...
| |
Open Access DOI:10.23937/2643-4563/1710027 Heidrun Männle, Birthe Osorio, Felix Momm and Karsten Münstedt Article Type: Review Article | First Published: March 13, 2021 Primary vaginal cancer represents a rare disease. The main risk factor for vaginal carcinoma is a persistent human papillomavirus (HPV) infection. However, chronic mechanic irritation of the vagina, have long been suspected to contribute to the development of vaginal cancer. This study examined to assess possible associations between genital prolapse and the incidence of vaginal cancer. We conducted a systematic literature search regarding the association between vaginal cancer and genital prola...
| |
Open Access DOI:10.23937/2643-4563/1710026 Cynthia Epskamp, Susanne M Huijts, Peter AHM van der Lubbe and Debbie G.J. Robbrecht Article Type: Original Article | First Published: February 10, 2021 Immune checkpoint inhibitor (ICI) treatment is an integral part of second line treatment of patients with urothelial carcinoma (UC) as well as in first line in cisplatin-ineligible patients with PD-L1 positive tumours. A substantial proportion of patients with bladder cancer have been treated with intravesical Mycobacterium bovis BCG in the past. Although it is rare, disseminated infections with Mycobacterium bovis have been described, but not in association with ICI treatment. We herein report ...
| |
Open Access DOI:10.23937/2643-4563/1710025 Rukmini Bezbaruah and Biren Parikh Article Type: Original Article | First Published: November 22, 2020 This was a retrospective study where cases of FL were collected from the department of Oncopathology, at a tertiary care centre over 3 years from January 2017 to December 2019. Statistical analysis was done using the Software Statistical Package for the Social Sciences (SPSS) Version 20. Age range was from 35 to 84 years. Out of 69 cases, 18 cases (26%) were grade I, 32 cases (46%) were grade II, and 19 cases (27%) were grade III. Ki67 showed significant correlation in case of grade, stage, FLIP...
| |
Open Access DOI:10.23937/2643-4563/1710024 Hussam Almasri, MD, Mahir Petkar, MBBS, MD, FRCPath, Abdulaziz Zafar, MBBS, MRCP, Mohammed Abuwahed, MBBS, Mohammad Altermanini, MBBCH, Rita Ahmad, MD and Mouhammad Sharaf Eldean, MD, FCAP Article Type: Case Report | First Published: June 19, 2020 Hepatosplenic T-cell lymphoma (HSGDTL) is a rare variant of T-cell lymphoma with few reported cases in literature. It usually presents with hepatosplenomegaly and constitutional symptoms, primarily in young to middle aged patients. The prognosis is generally poor, with maximum reported survival periods of 2-3 years. There is a link to immunodeficiency and some biological treatments. Liver biopsy with flow cytometry is required to confirm the diagnosis....
| |
Open Access DOI:10.23937/2643-4563/1710022 Shekhar Kumar Keshri, MBBS, DMRT, MD, Satyendra Narayan Sinha, MBBS, DNB and Mitali Dandekar Lall, MBBS, MS, DNB Article Type: Original article | First Published: May 20, 2020 Head and neck cancers pose a significant healthcare burden in India and more than two third of these patients present in advance stage. Multimodality treatment is recommended and often has detrimental impact on quality of life. A cross-sectional study was conducted from February-May 2019 among radically treated 73 head and neck cancer patients attending OPD for follow up using EORTC QLQ-C30 and QLQ H&N-35 questionnaires in Hindi language....
| |
Open Access DOI:10.23937/2643-4563/1710020 Geun-Jeon Kim, MD, Dong-Hyun Lee, MD, Chul-Woo Yang, MD, PhD and Dong-Il Sun, MD, PhD Article Type: Case Report | First Published: January 22, 2020 We report the co-occurrence of Duchenne muscular dystrophy (DMD) and mucoepidermoid carcinoma (MEC) of the parotid gland. A 33-year-old male presented with a parotid gland tumor of benign appearance. After surgery, the patient’s serum creatine kinase level exceeded 20,000 IU/L (normal, 50-200 IU/L); his potassium level was also high (7.2 mEq/L), as were his aspartate aminotransferase, alanine aminotransferase, and lactate dehydrogenase levels. Genetic testing revealed the deletion of exons 10-...
| |
Open Access DOI:10.23937/2643-4563/1710019 Alberto Garcia, MD, PhD, Angel Velarde, MD, MSCE, Francisco Quereda, MD, PhD, Jaume Ordi, MD, PhD, Orlando Rodas, MD, PhD, Erick Soch, MD, H Arturo Morales, MD, Federico Nave and Carlos Lopez, MD Article Type: Original Research | First Published: October 18, 2019 Conventional cytology is an economic method for screening abnormalities in cervical smears, but with implications in false positive and false negative as compared to better detection of transformed cells with the Dual staining P16/KI67 proteins in cervical smears, therefore, we evaluate the validity and reproducibility of cytology with double staining of P16 and KI67 as compared to conventional cytology in cervical smears. Participants were 210 Guatemalan women with abnormalities in conventional...
| |
Open Access DOI:10.23937/2643-4563/1710018 Hugo Ramiro Segura-Puello, Juan Sebastian Segura Charry, Diana Milena Munoz-Forero, Diana Lorena Nieto Mosquera and Andrea Catalina Villamil-Ballesteros Article Type: Original Article | First Published: October 16, 2019 At Cancer Research Laboratory of Manuela Beltran University (UMB), research was carried out with the design and development of the CIMT-54 biological vaccine: A combination of oncotropic virus + amino acids as adjuvants, which act directly on the tumor cell, preventing the reproduction of metastases to other organs and preventing the attack on healthy cells of the organism. The results at preclinical level suggested that the CIMT-54 vaccine is not cytotoxic; and on the other hand, in the studies...
| |
Open Access DOI:10.23937/2643-4563/1710017 Pharmacokinetics of Oxaliplatin in a Hemodialysis Patient with Metastatic Colon Cancer Yoshiaki Nagatani, Yoshinori Imamura, Tsutomu Nakamura, Kazuhiko Yamashita, Mamoru Okuno, Hiroyuki Yasui, Jun Hiraoka, Riho Niigata, Keiji Kono, Yasuko Hyogo, Hirotaka Suto, Kei Takenaka, Yohei Funakoshi, Masanori Toyoda, Naomi Kiyota and Hironobu Minami Article Type: Original Article | First Published: September 16, 2019 Although oxaliplatin is one of the main anticancer agents used against colorectal cancer, data on the pharmacokinetics of oxaliplatin in patients on hemodialysis are limited. In this case study, we evaluated the pharmacokinetics and safety of oxaliplatin in a patient on hemodialysis treated for colon cancer. A 68-year-old Japanese woman receiving chronic hemodialysis was treated for metastatic colon cancer with modified FOLFOX6 plus bevacizumab every 2 weeks. Initial oxaliplatin dose was reduc...
| |
Open Access DOI:10.23937/2643-4563/1710016 Nimotuzumab in Advanced Cervical Cancer: Safety and Efficacy Profile Raiza Ruiz Lorente, Sayly Alfonso, Yamilka Sanchez, Carmen Elena Viada, Ramon Ortiz, Mayelin Troche, Meylan Cepeda, Ana Rosa Vals, Leticia Cabrera, Annia Gorte, Delmis Maira Batista, Milagros Domenech, Jessica Garcia Viamontes, Conrado Ramos Mico and Mayra Ramos Suzarte Article Type: Review Article | First Published: July 29, 2019 The EGF receptor is over expressed in tumors of epithelial origin and is associated with a poor prognosis of the disease. An Expanded Clinical Access Program was carried out, in which patients with cervical uterine cancer in advanced stages of the disease without another therapeutic alternative were treated with nimotuzumab, anti-epidermal growth factor receptor humanized monoclonal antibody to evaluate the safety and efficacy of this therapy. Seventy-five patients with confirmed histological di...
| |
Open Access DOI:10.23937/2643-4563/1710015 Impact of the Number of Dissected Axillary Lymph Nodes on Survival in Breast Cancer Patients Emad Eldin Nabil, Ahmed M Maklad, Ashraf Elyamany, Emad Gomaa and Moamen M Ali Article Type: Research Article | First Published: June 05, 2019 For patients with breast cancer, axillary dissection was a standard treatment, especially with patient with positive metastases in the sentinel nodes. For some patients axillary dissection might be over-treatment, including those who have had a mastectomy. Especially with the new trend of many radiation-therapy centers, provide radiation-therapy for any number of positive lymph nodes. The aim of our work is to evaluate the impact of number of dissected axillary Lymph Nodes (LN), on Overall Survi...
| |
Open Access DOI:10.23937/2643-4563/1710014 Atypical Presentation of Denny-Brown Syndrome: A Case Report and Review of Literature Romeo V Porlas Jr, MD, Scott Riley K Ong, MD, Gerard Raimon Saranza, MD, FPNA and Jose Paciano B Reyes, MD, FPNA Article Type: Case Report | First Published: June 01, 2019 Paraneoplastic subacute sensory Denny-Brown neuronopathy
affects the peripheral nervous system and commonly
associated with small cell lung carcinoma and with other tumor
types in 14.4% of cases. Presented is a case of 23, female with progressive numbness
of extremities and ataxia. Investigations showed diffuse
sensory neuronopathy and elevated CSF IgG on CSF
studies. Paraneoplastic autoantibodies revealed negative
results yet imaging showed an anterior mediastinal mass,
which turned B-c...
| |
Open Access DOI:10.23937/2643-4563/1710013 Prostatic Ductal Adenocarcinoma: An Unusual Subtype of Prostate Cancer Dinesh Kumar, MBBS, MS and John Lobo, MD Article Type: Case Report | First Published: May 25, 2019 Ductal adenocarcinoma of the prostate (DAP) is defined as malignant epithelial cells filling large prostatic acini ducts, with preservation of basal cells forming either solid or dense cribriform patterns or a loose cribriform or micropapillary pattern with either marked nuclear atypia (nuclear size six times normal or larger) or Nonfocal comedonecrosis. DAP is a rare variant of prostate cancer, and has poorly-identified clinical characteristics....
| |
Open Access DOI:10.23937/2643-4563/1710012 Hydropneumopericardium: Unusual Complication of Proton Radiotherapy Nakamura Yasuhiro, MD Article Type: Clinical Image | First Published: May 13, 2019 Hydropnemopericardium is a very rare condition, which arises from penetrating trauma or blunt chest injury, development secondary to procedures, fistulization from adjacent structures and pericardial infections. This patient was 60-year-old man with hepatocellular carcinoma (HCC) presented to outpatients clinic with stomach pain, fatigue and anorexia. The patient was afebrile but laboratory profile manifested an excessive inflammatory response and disseminated intravascular coagulation. We detec...
| |
Open Access DOI:10.23937/ijor-2017/1710011 Effect of Specific Music on Psychoneuroimmunological Responses Abdul Waheed, David Kossor, William Collins and Amy Camie Article Type: ORIGINAL ARTICLE | First Published: December 31, 2018 A pilot study was done to measure quantitative EEG (qEEG) brainwave frequencies and behavioral indices of five women undergoing chemotherapy treatment for cancer, before and after listening to specific music (The Magic Mirror-Inspired Reflections solo harp CD written, performed and recorded by Amy Camie) once a day for ten days. Following treatments, the EEG profile for all five participants improved and subjective reports from daily questionnaires confirmed a positive effect of the music....
| |
Open Access DOI:10.23937/ijor-2017/1710010 Absorbed Radiation Dose in the Thyroid Gland Following Regional Nodal Irradiation for Breast Cancer Tahani Nageeti, Mohamed Mahfouz, Mazen Al Gaod and Reem Zatar Article Type: Original Article | First Published: November 19, 2018 Radiation exposure to the thyroid gland is unavoidable in breast cancer (BC) radiotherapy (RT). This study was conducted to evaluate the impact of using different supraclavicular (SCV) field angles on the percentage volume of the dose absorbed by the thyroid relative to the maximum dose absorbed by the spinal cord. A total of 50 consecutive BC patients undergoing planning computed tomography (CT) were evaluated. The thyroid gland, spinal cord, and SCV nodal volumes were contoured on the planning...
| |
Open Access DOI:10.23937/ijor-2017/1710009 Fadi Nasr, Ahmad Al Ghoche, Saada Diab, Janah Maddah, Layal Mansour, Ali kassem and Abd El Karim Gheith Article Type: Case Report | First Published: November 12, 2018 Despite of the high incidence of hepatocellular carcinoma (HCC), treatment strategies stays restrained. New treatment aspects remain a necessity to improve overall survival of patients. Here, we report for the first time a 2 years complete remission of hepatocellular carcinoma with pembrolizumab after failure of sorafenib and progression after liver transplantation. Immunotherapy became a field of interest in HCC for researchers and clinicians in order to establish new immunotherapy modalities t...
| |
Open Access DOI:10.23937/IJOR-2017/1710008 Organoids as Reliable Breast Cancer Study Models: An Update Andrew Octavian Sasmita and Ying Pei Wong Article Type: Review Article | First Published: October 06, 2018 Having been identified for centuries, breast cancer still remains one of the leading causes of death in women. Within the United States of America (USA) alone, it is estimated that over 60,000 women would have developed new cases of malignant breast cancer in 2017 alone; thus, calling an attention for the development of a reliable and effective breast cancer model for drug discovery to combat the disease or diagnostics to predict the progression of the disease. Current breast cancer models invol...
| |
Open Access DOI:10.23937/IJOR-2017/1710007 Economic Costs of Lung Cancer in China Shaoyu Fan, Zhengzhong Mao, Anita H Lee and Teh-wei Hu Article Type: Case Report | First Published: September 29, 2018 The estimated total national medical cost of treating lung cancer patients in China was 64.21 billion RMB (US$ 10.31 billion), about 2% of total medical costs in 2015. Total lung cancer costs in 2015 were 488.53 billion RMB (US$ 78.42 billion), about 75% of which can be attributed to mortality costs. Two-thirds of the lung cancer patients in the sample were either current or former smokers. The major economic costs of lung cancer among smokers are preventable. China has a relatively low cigarett...
| |
Open Access DOI:10.23937/ijor-2017/1710006 Ashraf Farrag, Arif Shaukat, Muhammad Ali and Magdy Kandil Article Type: Research Article | First Published: July 28, 2018 Oral cancer is the most common head and neck cancer (HNC). Its global incidence in 2015 was 410,000 cases with 146,000 deaths. In USA, 41,380 patients were diagnosed with HNC in 2013, and oral cavity cancers accounted for almost 30,000 of new cases. In Saudi Arabia, a total number of 211 oral cancer cases were reported in 2014, representing about 1.8% of the total cancer cases....
| |
Open Access DOI:10.23937/ijor-2017/1710005 Locoregional Breast Cancer Surgery: Is there a Role in the Presence of Metastatic Disease? J Bisnath, R Ramkissoon and J Ali Article Type: Case Report | First Published: June 11, 2018 Treatment of Stage Four Breast Cancer has traditionally excluded locoregional surgery, with the focus being on control of the distant disease. Much of what is applied in clinical practice is extrapolated from chemotherapy trials in the adjuvant setting, with taxanes and anthracyclines incorporated early on in the treatment course....
| |
Open Access DOI:10.23937/ijor-2017/1710004 Yoshiomi Hatayama, Masahiko Aoki, Hideo Kawaguchi, Katsumi Hirose, Mariko Sato, Ichitaro Fujioka, Mitsuki Tanaka, Koji Ichise, Shuichi Ono and Yoshihiro Takai Article Type: Original Article | First Published: March 31, 2018 Fifteen patients with locally advanced stage III pancreatic cancer underwent radiotherapy with or without concurrent chemotherapy between July 2006 and April 2014. We used 10 MV X-rays and multiple coplanar (two to four) fields. The number of fractions ranged between 20 and 28 with a fraction size of 1.8Gy. A total dose of 36-50.4Gy at the isocenter of the planning target volume (PTV) was administered to each patient. Fourteen patients received chemotherapy during radiotherapy. The cumulative su...
| |
Open Access DOI:10.23937/ijor-2017/1710003 Kazutaka Otsuji, Takeshi Sasaki, Keiichiro Tada, Masashi Fukayama and Yasuyuki Seto Article Type: Original Article | First Published: February 26, 2018 A new immunohistochemistry (IHC) method using fluorescence-emitting phosphor-integrated dot (PID) nanoparticles as a fluorescent dye was developed to accurately detect proteins that are expressed by cancer cells. This technique localizes proteins and quantitates their levels of expression in cancer lesions, which facilitates objective analysis of protein levels. We used the PID nanoparticle assay to measure HER2 expression in formalin-fixed, paraffin-embedded (FFPE) samples from patients with pr...
| |
Open Access DOI:10.23937/ijor-2017/1710002 Secretory Carcinoma of the Breast: An Elusive Presentation of This Rare Pathology Joseph Brandt, Jack Morgani, Alan Heimann and Edna Kapenhas Article Type: Case Report | First Published: November 16, 2017 Since first being noted in the literature in 1966, Secretory Breast Carcinoma (SBC) continues to be better defined in terms of its clinical, histologic, and genetic features. However, its unique presentation can elude seasoned practitioners from making a clinical diagnosis....
| |
Open Access DOI:10.23937/ijor-2017/1710001 Yasuhiro Nakmaura and Uch Somary Article Type: Review Article | First Published: November 01, 2017 Cambodia is considered to be endemic to chronic gastritis due to Helicobacter pylori (HP). Prevalence of HP is more than 70% inferred from the literature of neighboring countries. However, Cambodia, being a developing nation, doesn’t have enough resources for the screening of HP. On the other hand, after the Kyoto Global Consensus in 2015, risk evaluation of gastric carcinoma based on endoscopic findings with image-enhanced modalities and magnification allows diagnosis of gastritis with a high...
|
Editor-in-chief
ClinMed Archive
6
4
7
5
Articles Published
All articles are fully peer reviewed, free to access and can be downloaded from our ClinMed archive.
Contact our editorial office
ClinMed Journals Index Copernicus Values
Clinical Medical Image Library: 93.51
International Journal of Critical Care and Emergency Medicine: 92.83
International Journal of Sports and Exercise Medicine: 91.84
International Journal of Womens Health and Wellness: 91.79
Journal of Musculoskeletal Disorders and Treatment: 91.73
Journal of Geriatric Medicine and Gerontology: 91.55
Journal of Infectious Diseases and Epidemiology: 91.55
Clinical Medical Reviews and Case Reports: 91.40
International Archives of Nursing and Health Care: 90.87
International Journal of Ophthalmology and Clinical Research: 90.80
International Archives of Urology and Complications: 90.73
Journal of Clinical Nephrology and Renal Care: 90.33
Journal of Family Medicine and Disease Prevention: 89.99
Journal of Clinical Gastroenterology and Treatment: 89.54
Journal of Dermatology Research and Therapy: 89.34
International Journal of Clinical Cardiology: 89.24
International Journal of Radiology and Imaging Technology: 88.88
Obstetrics and Gynaecology Cases - Reviews: 88.42
International Journal of Blood Research and Disorders: 88.22
International Journal of Diabetes and Clinical Research: 87.97
New Issues